Tokyo Tape
Sign in
← Otsuka Holdings

Half-year report · HY

4578.TEDINET S100YTLB
Period2026-01-01 → 2026-06-30
Filed2026-07-31
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥1.33T2026-01-01 → 2026-06-30Cons.Revenue IFRS
Revenue¥2.47T2025-01-01 → 2025-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.18T2025-01-01 → 2025-06-30Cons.Revenue IFRS
Operating income¥278.5bn2026-01-01 → 2026-06-30Cons.Operating profit loss IFRS
Operating income¥242.1bn2025-01-01 → 2025-06-30Cons.Operating profit loss IFRS
Profit before tax¥285.4bn2026-01-01 → 2026-06-30Cons.Profit loss before tax IFRS
Profit before tax¥468.0bn2025-01-01 → 2025-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥226.3bn2025-01-01 → 2025-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥215.6bn2026-01-01 → 2026-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥363.1bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥173.5bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥218.5bn2026-01-01 → 2026-06-30Cons.Profit loss IFRS
Net income¥175.9bn2025-01-01 → 2025-06-30Cons.Profit loss IFRS
Total assets¥4.40Tat 2026-06-30Cons.Assets IFRS
Total assets¥4.20Tat 2025-12-31Cons.Assets IFRS
Total assets¥3.79Tat 2025-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥1.09Tat 2026-06-30Cons.Liabilities IFRS
Total liabilities¥1.10Tat 2025-12-31Cons.Liabilities IFRS
Net assets / equity¥3.31Tat 2026-06-30Cons.Equity IFRS
Net assets / equity¥3.10Tat 2025-12-31Cons.Equity IFRS
Net assets / equity¥2.79Tat 2025-06-30Cons.Equity IFRS
Net assets / equity¥2.78Tat 2024-12-31vCons.Equity IFRS
Equity (owners)¥3.24Tat 2026-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.03Tat 2025-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.72Tat 2025-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥469.5bnat 2026-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥534.6bnat 2025-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥411.1bnat 2025-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥426.2bnat 2024-12-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥217.1bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥403.6bn2025-01-01 → 2025-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥212.7bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥173.0bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥161.6bn2025-01-01 → 2025-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥130.9bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥114.3bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥137.3bn2025-01-01 → 2025-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥85.4bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥409.072026-01-01 → 2026-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥685.062025-01-01 → 2025-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥326.122025-01-01 → 2025-06-30Cons.Basic earnings loss per share IFRS
Equity ratio73.7%at 2026-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio72.3%at 2025-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.8%at 2025-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2026-01-01 → 2026-06-30¥65.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2026-01-01 → 2026-06-30¥63.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2026-01-01 → 2026-06-30¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2026-01-01 → 2026-06-30¥6.2bn
Reconciling Itemsreconcilingrevenue2026-01-01 → 2026-06-30−¥1.8bn
Reconciling Itemsreconcilingrevenue intersegment2026-01-01 → 2026-06-30−¥1.8bn
Reconciling Itemsreconcilingsegment profit2026-01-01 → 2026-06-30−¥28.7bn
Consumer Productsreportable segmentrevenue2026-01-01 → 2026-06-30¥17.5bn
Consumer Productsreportable segmentrevenue external2026-01-01 → 2026-06-30¥17.4bn
Consumer Productsreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥15m
Consumer Productsreportable segmentsegment profit2026-01-01 → 2026-06-30¥13.8bn
Nutraceuticalsreportable segmentrevenue2026-01-01 → 2026-06-30¥300.1bn
Nutraceuticalsreportable segmentrevenue external2026-01-01 → 2026-06-30¥300.1bn
Nutraceuticalsreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥16m
Nutraceuticalsreportable segmentsegment profit2026-01-01 → 2026-06-30¥36.8bn
Pharmaceuticalsreportable segmentrevenue2026-01-01 → 2026-06-30¥951.6bn
Pharmaceuticalsreportable segmentrevenue external2026-01-01 → 2026-06-30¥951.6bn
Pharmaceuticalsreportable segmentsegment profit2026-01-01 → 2026-06-30¥250.4bn
—segment totalrevenue2026-01-01 → 2026-06-30¥1.33T
—segment totalrevenue external2026-01-01 → 2026-06-30¥1.33T
—segment totalrevenue intersegment2026-01-01 → 2026-06-30¥1.8bn
—segment totalsegment profit2026-01-01 → 2026-06-30¥307.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥56.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥55.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-01-01 → 2025-06-30¥1.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30¥5.0bn
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥1.7bn
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥1.7bn
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥27.8bn
Consumer Productsreportable segmentrevenue2025-01-01 → 2025-06-30¥15.8bn
Consumer Productsreportable segmentrevenue external2025-01-01 → 2025-06-30¥15.8bn
Consumer Productsreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥9m
Consumer Productsreportable segmentsegment profit2025-01-01 → 2025-06-30¥12.9bn
Nutraceuticalsreportable segmentrevenue2025-01-01 → 2025-06-30¥276.1bn
Nutraceuticalsreportable segmentrevenue external2025-01-01 → 2025-06-30¥276.0bn
Nutraceuticalsreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥19m
Nutraceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥36.7bn
Pharmaceuticalsreportable segmentrevenue2025-01-01 → 2025-06-30¥833.8bn
Pharmaceuticalsreportable segmentrevenue external2025-01-01 → 2025-06-30¥833.8bn
Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥215.4bn
—segment totalrevenue2025-01-01 → 2025-06-30¥1.18T
—segment totalrevenue external2025-01-01 → 2025-06-30¥1.18T
—segment totalrevenue intersegment2025-01-01 → 2025-06-30¥1.7bn
—segment totalsegment profit2025-01-01 → 2025-06-30¥269.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 797
ItemContextValueUnit
Payments for purchase of treasury shares fin cf IFRSInterimDuration-29930000000JPY
Net increase decrease in short term borrowings fin cf IFRSPrior1InterimDuration869000000JPY
Net increase decrease in short term borrowings fin cf IFRSInterimDuration-1317000000JPY
Proceeds from long term borrowings fin cf IFRSPrior1InterimDuration－JPY
Proceeds from long term borrowings fin cf IFRSInterimDuration201000000JPY
Repayments of long term borrowings fin cf IFRSPrior1InterimDuration-822000000JPY
Repayments of long term borrowings fin cf IFRSInterimDuration-1313000000JPY
Proceeds from issuance of bonds fin cf IFRSPrior1InterimDuration30000000000JPY
Proceeds from issuance of bonds fin cf IFRSInterimDuration－JPY
Redemption of bonds fin cf IFRSPrior1InterimDuration－JPY
Redemption of bonds fin cf IFRSInterimDuration-30000000000JPY
Repayments of lease obligations fin cf IFRSPrior1InterimDuration-11843000000JPY
Repayments of lease obligations fin cf IFRSInterimDuration-12863000000JPY
Dividends paid fin cf IFRSPrior1InterimDuration-33489000000JPY
Dividends paid fin cf IFRSInterimDuration-38853000000JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSPrior1InterimDuration－JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSInterimDuration-225000000JPY
Other fin cf IFRSPrior1InterimDuration－JPY
Other fin cf IFRSInterimDuration-12000000JPY
Net cash provided by used in financing activities IFRSPrior1InterimDuration-85383000000JPY
Net cash provided by used in financing activities IFRSInterimDuration-114315000000JPY
Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRSPrior1InterimDuration-3600000000JPY
Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRSInterimDuration-70215000000JPY
Cash and cash equivalents IFRSPrior2YearInstant426173000000JPY
Cash and cash equivalents IFRSPrior1YearInstant534645000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1InterimDuration-11461000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSInterimDuration5118000000JPY
Cash and cash equivalents IFRSPrior1InterimInstant411111000000JPY
Cash and cash equivalents IFRSInterimInstant469548000000JPY
Revenue from external customers IFRSPrior1InterimDuration_jpcrp040300-ssr_E21183-000PharmaceuticalsReportableSegmentMember833782000000JPY
Revenue from external customers IFRSPrior1InterimDuration_jpcrp040300-ssr_E21183-000NutraceuticalsReportableSegmentMember276038000000JPY
Revenue from external customers IFRSPrior1InterimDuration_jpcrp040300-ssr_E21183-000ConsumerProductsReportableSegmentMember15836000000JPY
Revenue from external customers IFRSPrior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember55110000000JPY
Revenue from external customers IFRSPrior1InterimDuration_ReportableSegmentsMember1180766000000JPY
Revenue from external customers IFRSPrior1InterimDuration_ReconcilingItemsMember－JPY
Revenue from external customers IFRSPrior1InterimDuration1180766000000JPY
Intersegment revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E21183-000PharmaceuticalsReportableSegmentMember－JPY
Intersegment revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E21183-000NutraceuticalsReportableSegmentMember19000000JPY
Intersegment revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E21183-000ConsumerProductsReportableSegmentMember9000000JPY
Intersegment revenue IFRSPrior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1633000000JPY
Intersegment revenue IFRSPrior1InterimDuration_ReportableSegmentsMember1661000000JPY
Intersegment revenue IFRSPrior1InterimDuration_ReconcilingItemsMember-1661000000JPY
Intersegment revenue IFRSPrior1InterimDuration－JPY
Revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E21183-000PharmaceuticalsReportableSegmentMember833782000000JPY
Revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E21183-000NutraceuticalsReportableSegmentMember276057000000JPY
Revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E21183-000ConsumerProductsReportableSegmentMember15845000000JPY
Revenue IFRSPrior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember56743000000JPY
Revenue IFRSPrior1InterimDuration_ReportableSegmentsMember1182428000000JPY
Revenue IFRSPrior1InterimDuration_ReconcilingItemsMember-1661000000JPY
Revenue IFRSPrior1InterimDuration1180766000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-12-31pass
balance sheet identityconsolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2026-01-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2026-01-01/2026-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsconsolidated 2026-06-30pass